Atossa Genetics Announces Publication of Mammary Aspirate Specimen Cytology Test (MASCT) System Clinical Trial Results SEATTLE, WA--(Marketwired - Aug 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced the publication of a peer-reviewed paper titled "A phase I safety...

Atossa Genetics Appoints Tim Hunkapiller, Ph.D., to Its Scientific Advisory Board SEATTLE, WA--(Marketwire - Apr 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...

Atossa Genetics, Inc. Appoints Robert L. Kelly as President SEATTLE, WA--(Marketwire - May 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...